3 completed, 3 recruiting, 1 active not recruiting, 1 withdrawn. 8 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 3, Recruiting 3, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 5 | Recruiting 3, Active not recruiting 1, Completed 1 |
Follow Metastatic Malignant Neoplasm in the Lung: new trials by email Literature Review of Metastatic Malignant Neoplasm in the Lung trials Research Report on Metastatic Malignant Neoplasm in the Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung Aerosol Sargramostim, Biospecimen Collection, Computed Tomography - Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Lung | Phase 1 | Withdrawn | Mayo Clinic | 2025-10-28 | 2025-08-07 | |
| Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies Hafnium Oxide-containing Nanoparticles NBTXR3, Radiation Therapy - Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2023-05-08 | 2026-07-30 |
| Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases Cisplatin, Isolated Chemotherapeutic Lung Perfusion, Metastasectomy - Metastatic Bone Sarcoma, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Recruiting | Roswell Park Cancer Institute | 99 | 2020-07-16 | 2026-08-21 |
| Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Completed | University of Washington | 20 | 2019-01-15 | 2023-12-29 |
| Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Recruiting | Stanford University | 30 | 2018-07-19 | 2026-10-05 |
| CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy CAPP-Seq, Isovue-200, Computed Tomography Perfusion Imaging - Malignant Lung Neoplasm, Metastatic Malignant Neoplasm in the Lung | Phase 1 | Completed | Stanford University | 19 | 2016-01-19 | 2023-11-22 |
| Aerosolized Aldesleukin in Treating Patients With Lung Metastases Aerosolized Aldesleukin, Laboratory Biomarker Analysis - Metastatic Malignant Neoplasm in the Lung, Metastatic Melanoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 70 | 2012-06-28 | 2026-10-15 |
| Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis Cisplatin, Pharmacological Study - Metastatic Malignant Neoplasm in the Lung, Stage IIIB Non-Small Cell Lung Cancer | Phase 1 | Completed | Roswell Park Cancer Institute | 11 | 2007-12-04 | 2022-07-25 |
Sarcoma (3) · Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Melanoma (2) · Bone Neoplasms (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Neoplasm Metastasis (1) · Osteosarcoma (1) · Salivary Gland Neoplasms (1)
Neoplasms (8) · Neoplasms by Site (7) · Neoplasms by Histologic Type (4) · Lung Diseases (3) · Neoplasms, Connective and Soft Tissue (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Nevi and Melanomas (2)
1,2-diaminocyclohexaneplatinum II citrate (2) · Cisplatin (2) · Nivolumab (2) · Platinum (2) · CTLA-4 Antigen (1) · Cytidine Triphosphate (1) · Iopamidol (1) · Iothalamic Acid (1) · Ipilimumab (1) · Magnetic Resonance Spectroscopy (1) · Metastasectomy (1) · Pharmacogenomic Variants (1) · Radiation (1) · Radiosurgery (1) · Radiotherapy (1)
M.D. Anderson Cancer Center (2) · Roswell Park Cancer Institute (2) · Stanford University (2) · Mayo Clinic (1) · University of Washington (1)
United States (8)
Chukwumere Nwogu (1) · Cristina Rodriguez (1) · Kenneth Seastedt (1) · Maximilian Diehn (1) · Najat Daw (1) · Natalie Lui (1) · Saumil Gandhi, MD (1) · Svetomir N. Markovic, M.D., Ph.D. (1)